These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8489655)

  • 21. Distinct expression of cell-cell and cell-matrix adhesion molecules on endothelial cells in human heart and lung transplants.
    Steinhoff G; Behrend M; Richter N; Schlitt HJ; Cremer J; Haverich A
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1145-55. PubMed ID: 8719462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of autoimmunity in the pathogenesis of lung allograft rejection.
    Wilkes DS
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):227-30. PubMed ID: 12956431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A perspective on the Revised Working Formulation for the grading of lung allograft rejection.
    Yousem S
    Transplant Proc; 1996 Feb; 28(1):477-9. PubMed ID: 8644317
    [No Abstract]   [Full Text] [Related]  

  • 24. Endothelial cell chimerism associated with graft rejection after human lung transplantation.
    Murata H; Ratajczak P; Meignin V; Groussard O; Fournier M; Socié G; Mal H; Janin A
    Transplantation; 2008 Jan; 85(1):150-4. PubMed ID: 18192926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation.
    Berry GJ; Brunt EM; Chamberlain D; Hruban RH; Sibley RK; Stewart S; Tazelaar HD
    J Heart Transplant; 1990; 9(6):593-601. PubMed ID: 2277294
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrence of primary disease in a single lung transplant recipient.
    Barberis M; Harari S; Tironi A; Lampertico P
    Transplant Proc; 1992 Dec; 24(6):2660-2. PubMed ID: 1465892
    [No Abstract]   [Full Text] [Related]  

  • 27. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.
    Nair RV; Huang X; Shorthouse R; Adams B; Brazelton T; Braun-Dullaeus R; Morris RE
    Transplant Proc; 1997; 29(1-2):614-5. PubMed ID: 9123154
    [No Abstract]   [Full Text] [Related]  

  • 29. Transvenous lung biopsy: a new technique.
    Hakim M; Stovin P; English T; Wallwork J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2573. PubMed ID: 3274566
    [No Abstract]   [Full Text] [Related]  

  • 30. Yield of surveillance transbronchial biopsies performed beyond two years after lung transplantation.
    Kesten S; Chamberlain D; Maurer J
    J Heart Lung Transplant; 1996 Apr; 15(4):384-8. PubMed ID: 8732597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart/lung transplantation in Australia: early results of the St Vincent's program.
    Spratt P; Glanville AR; MacDonald P; Farnsworth A; Bryant D; Keogh A; Chang VP
    Transplant Proc; 1990 Oct; 22(5):2141-2. PubMed ID: 2219322
    [No Abstract]   [Full Text] [Related]  

  • 32. Eosinophil activation in cardiac and pulmonary acute allograft rejection.
    Dosanjh AK; Robinson TE; Strauss J; Berry G
    J Heart Lung Transplant; 1998 Oct; 17(10):1038. PubMed ID: 9811417
    [No Abstract]   [Full Text] [Related]  

  • 33. Nicotine attenuates macrophage infiltration in rat lung allografts.
    Hirschburger M; Zakrzewicz A; Kummer W; Padberg W; Grau V
    J Heart Lung Transplant; 2009 May; 28(5):493-500. PubMed ID: 19416779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart-lung transplantation.
    Yousem SA
    Perspect Pediatr Pathol; 1989; 13():82-104. PubMed ID: 2697855
    [No Abstract]   [Full Text] [Related]  

  • 35. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
    J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal pattern of transfusion and its relation to rejection after lung transplantation.
    Mason DP; Little SG; Nowicki ER; Batizy LH; Murthy SC; McNeill AM; Budev MM; Mehta AC; Pettersson GB; Blackstone EH
    J Heart Lung Transplant; 2009 Jun; 28(6):558-63. PubMed ID: 19481015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood.
    Pierson RN; Pino-Chavez G; Young VK; Kaspar-Konig W; White DJ; Wallwork J
    J Heart Lung Transplant; 1997 Feb; 16(2):231-9. PubMed ID: 9059935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial biopsy in heart and heart-lung transplantation.
    Billingham ME
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Sep; 37 Suppl():66. PubMed ID: 2584797
    [No Abstract]   [Full Text] [Related]  

  • 39. The natural history of chronic rejection in heart-lung transplant recipients: a clinical, pathological, and physiological review of 29 long-term survivors.
    Scott JP; Higenbottam TW; Clelland CA; Smyth RL; Stewart S; Wallwork J
    Transplant Proc; 1990 Aug; 22(4):1474-6. PubMed ID: 2389371
    [No Abstract]   [Full Text] [Related]  

  • 40. Which are the target vessels of xeno- and allo-lung rejection?--a primate single lung transplantation study.
    Kawauchi M; Takeda M; Matsumoto J; Nakajima J; Furuse A; Oka T; Yoshitake T
    Transplant Proc; 1996 Jun; 28(3):1416-7. PubMed ID: 8658719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.